How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code SBH: Integrated Continuous Glucose Monitor For Non-Intensive Glucose Management, Over-The-Counter. View classification details, related manufacturers, 510(k) clearances, and recall records.
An integrated continuous glucose monitoring system (iCGM) for non-intensive glucose management is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time to detect euglycemic and dysglycemic glucose levels across the range spanning clinically significant hypoglycemia and hyperglycemia levels in persons who are not on insulin and who do not have a significant risk of problematic hypoglycemia. iCGM systems for non-intensive glucose management are designed to reliably and securely transmit glucose measurement data to digitally connected devices, excluding devices intended to control the delivery of insulin, and are intended to be used alone or in conjunction with these digitally connected medical devices.Explore clinical chemistry records →
3 clearance records and 0 recall records in the covered releases, across 2 source company names and 1 product codes. Dated history runs from Jun 7, 2024 to Aug 11, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 1 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 1 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| SBH · Integrated Continuous Glucose Monitor For Non-Intensive Glucose Management, Over-The-Counter | 3 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Stelo Glucose Biosensor SystemK262472 · SBH | Dexcom, Inc. | 510(k) | Aug 11, 2026FDA decision date |
| Stelo Glucose Biosensor SystemK260935 · SBH | Dexcom, Inc. | 510(k) | Jun 12, 2026FDA decision date |
| Libre Rio Continuous Glucose Monitoring SystemK233861 · SBH | Abbott Diabetes Care | 510(k) | Jun 7, 2024FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 21, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.